osi-7904l
Small moleculeexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2003 (NCT00116896)
Timeline
Indications
Mechanism of action
- Thymidylate synthaseINHIBITOR
TYMS inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- osi 7904l
- osi 7904l
- osi-7904l
- osi-7904l
- osi-7904l
- osi-7904l
- ((s)-2-(5-(1,2-dihydro-3-methyl-1-oxobenzo(f)-quinazoline-9-yl)methyl)amino-1-oxo-2-isoindolynyl)-glutaric acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00088270 | Phase 2 | Aug 1, 2004 | OSI Pharmaceuticals |
| NCT00116909 | Phase 2 | Aug 1, 2004 | OSI Pharmaceuticals |
| NCT00081237 | Phase 1 | Feb 1, 2004 | European Organisation for Research and Treatment of Cancer, Gottfried Wilhelm Leibniz Universität Hannover |
| NCT00073502 | Phase 2 | Oct 1, 2003 | OSI Pharmaceuticals |
| NCT00116896 | Phase 1 | Jun 1, 2003 | OSI Pharmaceuticals |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| OSI Pharmaceuticals | For profit | 4 | 4 | 2 | 2003 |
| European Organisation for Research and Treatment of Cancer | Academic/Hospital | 1 | 1 | 1 | 2004 |
| Gottfried Wilhelm Leibniz Universität Hannover | Academic/Hospital | 1 | 0 | 1 | 2004 |
3 organizations
Page 1 / 1